The product has been added to your shopping cart Show shopping cartCheckout
Your browser is not supported. For the best experience, a newer version or another browser is recommended.
In order to give you better service we use cookies. By continuing to browse the site you are agreeing to our use of cookies.
Lung adenocarcinoma stained with Napsin A antibody

Napsin A 1,0 mL

BC-CM388CK
Not in stock
Product question

What would you like to know about Napsin A 1,0 mL?

Send

Description

Specifications
Intended Use: IVD
Source: Mouse Monoclonal
Species Reactivity: Human, Others not tested
Clone: TMU-Ad 02
Isotype: IgG1
Antigen: Synthetic peptide of a part of the N-terminus of human Napsin A
Cellular Localization: Cytoplasmic
Positive Control: Lung adenocarcinoma
Normal Tissue: Kidney
Abnormal Tissue: Kidney

Napsin A is a pepsin-like aspartic proteinase. It is expressed in type II pneumocytes and in adenocarcinomas of the lung and kidney. Studies have shown that Napsin A is both more sensitive and specific than TTF-1. When compared to TTF-1, Napsin A showed a higher specificity (94.3%) for adenocarcinoma in non-small cell lung carcinoma as compared to TTF-1 (76.1%). Unlike TTF-1, Napsin A is positive in some renal cell carcinomas (RCC). Several studies have shown that Napsin A was positive in 83%-90.7% of primary lung adenocarcinomas. Other neoplastic tissues such as ovarian cancers show low expression with different staining patterns from that of primary lung cancer which shows granular cytoplasmic staining in tumor cells. In studies comparing TTF-1 and SP-A, Napsin A stained more tumor cells and a higher percentage of lung adenocarcinomas than either of these antibodies. Napsin A is useful for distinguishing primary lung adenocarcinoma from adenocarcinoma of unknown origin and is therefore a promising marker for the diagnosis of primary lung adenocarcinoma.

More ...Close